MIGHTY MEDIC

Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast

  • Home
  • Cos'è MIGHTY MEDIC
  • Lo Statuto
  • Comitato Scientifico
  • Centri partecipanti
  • Eventi e congressi
    • LipidClub 2014
  • News
  • Publications alert
  • Mappa del sito
  • Sponsor
  • La storia
  • Link

LipidClub 2014 - Program and presentations

Nota: sono disponibili solo le presentazioni autorizzate alla pubblicazione. I diritti delle presentazioni appartengono ai rispettivi Autori; qualora vengano riprodotte è fatto obbligo di indicarne la fonte ("Courtesy of...")

The present treatment of elevated Lp(a) and CVD prevention:
lipid-apheresis

Patrick Moriarty

Effect of lipoprotein apheresis on cardiovascular events in
patients with elevated Lipoprotein (a) levels

Ulrich Julius

Familial Hypercholesterolaemia: genetic testing and problems
related to the development of a target therapy

Clara Balsano

Treatment of HoFH by Lomitapide. Long-term extension study:
preliminary outcome

Claudia Stefanutti

Hyperlipidaemia in children
Ornella Guardamagna

To promote health through the European research infrastructures
Elena Bravo

Potential of the H.E.L.P. apheresis in the treatment of ischemic
stroke and some other peculiar indications

Beate Jaeger

Chronic Kidney Disease as cardiovascular risk predictor.
Evidence based clinical management

Fabio Mazza

© 2013 Andrea Petta Email

  • Home > 
  • Eventi e congressi > 
  • LipidClub 2014 >